Physician profile
Brian D Bull
NPI 1023089679
$2,572.68
in general payments reported to CMS, 2019-2025
25 companies · $66.08 in 2025
The $66.08 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $822 · 2020: $456 · 2021: $455 · 2022: $416 · 2023: $295 · 2024: $62.91 · 2025: $66.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $342.75 | 2019-2024 | Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $298.31 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $202.31 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $197.87 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $189.73 | 2019-2022 | |
| Abbvie INC. | $153.10 | 2021-2025 | Vraylar |
| Janssen Pharmaceuticals, INC | $147.93 | 2019-2022 | |
| Lilly USA, LLC | $143.58 | 2020-2024 | Emgality, Jardiance, Mounjaro |
| Abbott Laboratories | $131.67 | 2021-2023 | Freestyle Libre 3 |
| Allergan, INC. | $128.33 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $100.68 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $88.12 | 2020-2022 | |
| Medtronic, INC. | $84.79 | 2021 | |
| Amarin Pharma, INC. | $74.05 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $49.65 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $45.84 | 2019 | |
| Esperion Therapeutics, INC. | $34.10 | 2021-2023 | Nexletol |
| Novartis Pharmaceuticals Corporation | $29.25 | 2019-2022 | |
| Amgen INC. | $26.03 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.61 | 2019-2021 | |
| Sanofi Pasteur INC. | $21.34 | 2022 | |
| Exact Sciences Corporation | $15.70 | 2023 | Cologuard Collection Kit |
| Dexcom, INC. | $15.49 | 2021 | |
| Genentech USA, INC. | $15.16 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Bull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.